Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Friday, April 19, 2024 | Back issues
Courthouse News Service Courthouse News Service

Cymbalta

SACRAMENTO - More than 17 people claim Eli Lilly failed to warn of the frequency and severity of withdrawal symptoms from Cymbalta, a selective serotonin reuptake inhibitor it introduced when it lost its patent on Prozac, in Federal Court.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...